Sleep Disturbance in Lung Cancer Patients.

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by University Hospital, Angers.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
University Hospital, Angers
ClinicalTrials.gov Identifier:
NCT00187980
First received: September 9, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
  Purpose

The aim of this study is to 1-evaluate subjectively by questionnaires and objectively by ambulatory actigraphy the quality of sleep in patients with newly diagnosed lung cancer; 2- to correlate sleep quality index with quality of life, daytime alertness, Performans status and lung cancer staging at diagnosis.


Condition
Lung Cancer

Study Type: Observational
Study Design: Observational Model: Defined Population
Time Perspective: Longitudinal

Resource links provided by NLM:


Further study details as provided by University Hospital, Angers:

Estimated Enrollment: 50
Study Start Date: June 2005
  Eligibility

Ages Eligible for Study:   18 Months and older
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Newly diagnosed lung cancer age > 18 yrs Performans status < 3 Informed consent Life expectancy > 5 months

Exclusion Criteria:

Psychiatric disease Performans status > 2 Known sleep disorder

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00187980

Contacts
Contact: Yannick Le Guen, MD 33(0)241355844 yaleguen@chu-angers.fr

Locations
France
UH Recruiting
Angers, France, 49033 cedex
Contact: Yannick Le Guen, MD    33(0)241355844    yaleguen@chu-angers.fr   
Sponsors and Collaborators
University Hospital, Angers
Investigators
Principal Investigator: Yannick Le Guen University Hospital, Angers
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00187980     History of Changes
Other Study ID Numbers: CP 05-02
Study First Received: September 9, 2005
Last Updated: September 9, 2005
Health Authority: France: Direction générale de la santé-French General Health Administration

Additional relevant MeSH terms:
Lung Neoplasms
Respiratory Tract Neoplasms
Thoracic Neoplasms
Neoplasms by Site
Neoplasms
Lung Diseases
Respiratory Tract Diseases

ClinicalTrials.gov processed this record on August 28, 2014